Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Deals
Features
News
Region
Sectors
Size

Size

Prenetics tests out $1.25bn reverse merger
Genetic testing services provider Prenetics, a spinout of City University of Hong Kong, will hold a reverse merger at a $1.25bn valuation.
Hydrogenious LOHC fuels up on funding
Erlangen-Nürnberg spinout Hydrogenious LOHC Technologies has added $59m to its coffers.
EnerVenue electrifies $100m series A
Stanford University has backed a round that will help the nickel-hydrogen battery developer finance construction of a Gigafactory.
Daily deal net: September 15, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Context Therapeutics frames IPO plans
Based on research at Drexel University, Context Therapeutics is seeking to raise up to $21m in an initial public offering on Nasdaq.
Vanqua Bio wins over series B investors
Osage University Partners is among the investors in Northwestern spinout Vanqua Bio’s $85m series B round.
AgBiome cultivates $116m series D
UNC Chapel Hill’s agricultural technology developer AgBiome has increased its overall funding to $230m following the series D round.
Daily deal net: September 14, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

News Continued

TreeFrog dives into $75m series B
The stem cell therapy developer, exploiting research from Digital Photonics and Nanoscience Laboratory, has set up a US subsidiary.
Prospection delves into $33m series B
Main Sequence Ventures has returned for Prospection’s series B round, having already participated in the company’s $6.7m series A last year.
Daily deal net: September 13, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Lexeo Therapeutics bags $100m
Cornell spinout Lexeo Therapeutics has added $100m to its coffers thanks to a series B round co-led by D1 Capital Partners and Eventide Asset Management.
Exscientia explores Nasdaq IPO
Dundee spinout Exscientia is continuing a busy fundraising year with a filing for an IPO in the US and a $35m concurrent private placement.
Daily deal net: September 10, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Editor's Picks

Aerovate accesses public markets
Less than a year after raising $72.6m in its series A round, Aerovate Therapeutics has gone public following an IPO worth more than $121m.
Big deal: Oxford PV begins capturing series D
Goldwind, Legal & General and Equinor have all taken part in a series D that achieved a $41m first close and boosted the Oxford spinout’s total equity and debt to more than $118m.
Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Big deal: Orchard harvests $200m IPO
Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.
test reg

Login